Lymphocytapheresis in chronic progressive multiple sclerosis: Results of a preliminary trial

J. Rose, H. Klein, J. Greenstein, D. McFarlin, L. Gerber, H. McFarland

Research output: Contribution to journalArticlepeer-review

Abstract

Lymphocytapheresis remains an expensive and investigational therapy that produces transient depletion of circulating lymphocytes in patients with MS. This study indicates that lymphocytapheresis alone does not prevent further progression of rapidly progressive MS. Although short-term clinical improvement was observed in some of the patients with more slowly progressive disease, a placebo effect cannot be excluded, and only a controlled trial will establish if the improvement is related to the treatment. At present this form of treatment cannot be recommended outside of clinical trials.

Original languageEnglish (US)
Pages (from-to)593-594
Number of pages2
JournalAnnals of Neurology
Volume14
Issue number5
StatePublished - 1983
Externally publishedYes

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint

Dive into the research topics of 'Lymphocytapheresis in chronic progressive multiple sclerosis: Results of a preliminary trial'. Together they form a unique fingerprint.

Cite this